Jill Aichroth

Director Talent Acquisition at Treace Medical Concepts, Inc.

Jill Aichroth has a diverse background in talent acquisition and recruitment. Jill is currently the Director of Talent Acquisition at Treace Medical Concepts, Inc., where they focus on advancing the standard of care for bunion deformities and midfoot correction.

Before joining Treace Medical Concepts, Inc., Jill held various roles at Korn Ferry, starting as a Senior Talent Acquisition Business Partner in 2015 and eventually becoming a Team Lead, providing services to companies like Novartis and Teva Pharm.

Prior to their time at Korn Ferry, Jill worked as a Senior Recruiter at Randstad and as a Healthcare Recruiter at Chenega Corporation EH&F. Jill also served as a Human Resources Recruiter on a contract basis at Sovereign Bank.

Earlier in their career, Jill gained experience as a Senior Corporate Recruiter at Aon, a Senior Manager at Nursefinders, a Corporate Contract Recruiter at Olympus Corporation of the Americas, and a Senior Healthcare Recruiter at Maxim Healthcare Services.

Jill's career in talent acquisition began at Global Employment Solutions, where they worked as a Recruiter for five years.

Jill Aichroth obtained their A.A degree in Occupational Studies from Katharine Gibbs School of Business in the years 1998 to 2001. Following this, they pursued a Bachelors degree in Science in Management from the University of Phoenix from 2008 to 2010. Most recently, Jill completed their Master of Science degree in Management and Leadership from Western Governors University between 2017 and 2018.

Location

St. Augustine, United States

Links

Previous companies


Org chart


Teams


Offices


Treace Medical Concepts, Inc.

1 followers

Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 65 million Americans1, of which Treace estimates 1.1 million are annual surgical candidates. Treace Medical has pioneered and patented the Lapiplasty® 3D Bunion Correction™ system – a combination of instruments, implants, and surgical methods designed to surgically correct all 3 planes of the bunion deformity and secure the unstable joint, addressing the root cause2,3 of the bunion and helping patients get back to their active lifestyles. Treace Medical has expanded its offering with the Adductoplasty™ Midfoot Correction System, designed for reproducible surgical correction of the midfoot to provide further support to hallux valgus patients. For more information, please visit www.treace.com. The content herein is for informational purposes and intended for healthcare professionals only. Treace Medical Concepts, Inc. does not dispense medical advice. A surgeon should rely on his or her own professional clinical judgment when deciding whether to use a specific product when treating a particular patient. Prior to use of the device, the surgeon should refer to the instructions for use for complete indications, contraindications, warnings, and risks. For complete risk and benefit information, visit Treace.com. **Please note** Treace Medical will make an offer of employment only to individuals who have applied for a position using our official application. Be on alert for possible fraudulent offers of employment. Treace Medical will not solicit money or banking information from applicants. 1Nix S, et al. J Foot Ankle Res. 2010. 27:3:21. 2Dayton P, et al. J Foot Ankle Surg. 2016;55:567-71. 3Dayton P, et al. J Foot Ankle Surg. 2018;57:766-770.


Employees

201-500

Links